In RA, new use of JAK inhibitors was associated with nonmelanoma skin cancer vs. TNF inhibitors at 2 y. Schattner A. Ann Intern Med 2023 Jul 4. doi: 10.7326/J23-0042.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Schattner A. In RA, new use of JAK inhibitors was associated with nonmelanoma skin cancer vs. TNF inhibitors at 2 y. Ann Intern Med 2023 Jul 4. doi: 10.7326/J23-0042.
PMID: 37399557